Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for Non-motor Symptoms in Parkinson's Disease
NCT01300819Phase 4Completed
- Sponsor
- UCB
- Start
- Feb 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Placebo with Rotigotine (2 arms). Primary endpoint: Total Non-Motor Symptoms Scale Score at 12 weeks. Started Feb 2011; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01300819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300819.